不同评分模型预测冠心病患者经皮冠状动脉介入治疗术后出血并发症的价值

Value of Various Scoring Models in Predicting Bleeding Complications After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease

冠心病患者经皮冠状动脉介入治疗术后抗血小板治疗相关的出血并发症可导致不良的临床后果,有时甚至是致命性的,因此制定抗血小板治疗方案前应仔细评估出血风险。近些年,不同评分模型被提出,用于对冠心病患者的出血风险进行危险分层,以指导抗血小板治疗的强度和疗程以及改善患者的预后。然而,不同的评分模型有其各自的适用人群与范围、优点及临床局限性,各评分模型之间有其相通之处和不同之处,因此如何选择或联用出血评分系统对指导临床诊疗决策相当重要。现就不同评分模型在冠心病患者中的应用做一综述。

Antiplatelet therapy related bleeding complications in coronary heart disease patients after percutaneous coronary intervention can lead to adverse clinical outcomes and sometimes be fatal,therefore the risk of bleeding should be carefully evaluated before formulating antiplatelet therapy regimen.In recent years,various scoring models have been proposed to make bleeding risk stratification for coronary heart disease patients,which can guide the intensity and duration of antiplatelet therapy and improve the prognosis of patients.However,various scoring models have their own applicable population and scope,clinical advantages and limitations,and have some similarities and differences.How to choose or combine the bleeding scoring systems is quite important to guide the decision-making of clinical diagnosis and treatment.This article reviews the value of various scoring models to predict bleeding complications.